SHELTON, Conn., July 21 /PRNewswire/ -- Cara Therapeutics, Inc. announced today that it had closed on a Series D financing of $15 million. The round was led by new investor, Rho Ventures, with participation from previous investors Alta Biopharma, Ascent Biomedical Ventures, CT Innovations, Devon Park BioVentures, Healthcare Private Equity, Mitsubishi International Corporation and MVM Life Science Partners.
Texas Health Dallas Recognized for Minimally-Invasive Women's Surgeries
Hospital named academic center of excellence for leading-edge gynecological surgery
DALLAS, July 6 /PRNewswire-USNewswire/ -- Texas Health Presbyterian Hospital Dallas is the first hospital in Texas — and one of only three in the United States — to be named a Center of Excellence for gynecological surgery by the American Institute for Minimally Invasive Surgery (AIMIS).
(Photo: http://www.newscom.com/cgi-bin/prnh/20100706/DC29919)
(Photo: http://photos.prnewswire.com/prnh/20100706/DC29919)
The recognition is being given to Texas Health Dallas for its high volume of minimally-invasive women's surgeries and superior patient outcomes.
"Being named a center of excellence is exciting, but it's most rewarding to know we're doing what's b...
Simbionix and USF Receive Grant to Support Development of Laparoscopic Hysterectomy Simulation
CLEVELAND, Ohio, June 30, 2010 /PRNewswire/ -- Simbionix Ltd., a
subsidiary of Simbionix USA Corporation, the world's leading provider of
medical education and simulation training products for medical professionals
and the healthcare industry, and USF Health, an organization dedicated to
creating a model of health care based on understanding the full spectrum of
health, are proud to announce that together they received a BIRD (Binational
Industrial Research and Development) Grant to support the development of a
Laparoscopic Hysterectomy simulation module.
The BIRD Foundation was established by the U.S.
